Literature DB >> 22417311

MiR-21 is up-regulated in psoriasis and suppresses T cell apoptosis.

Florian Meisgen, Ning Xu, Tianling Wei, Peter C Janson, Susanna Obad, Oliver Broom, Nikoletta Nagy, Sakari Kauppinen, Lajos Kemény, Mona Ståhle, Andor Pivarcsi, Enikö Sonkoly.   

Abstract

MicroRNAs are short non-coding RNAs that regulate gene expression. Previously, in a genome-wide screen, we found deregulation of microRNA expression in psoriasis skin. MicroRNA-21 (miR-21) is one of the microRNAs significantly up-regulated in psoriasis skin lesions. To identify the cell type responsible for the increased miR-21 level, we compared expression of miR-21 in epidermal cells and dermal T cells between psoriasis and healthy skin and found elevated levels of miR-21 in psoriasis in both cell types. In cultured T cells, expression of miR-21 increased markedly upon activation. To explore the function of miR-21 in primary human T helper cells, we inhibited miR-21 using a tiny seed-targeting LNA-anti-miR. Specific inhibition of miR-21 increased the apoptosis rate of activated T cells. Our results suggest that miR-21 suppresses apoptosis in activated T cells, and thus, overexpression of miR-21 may contribute to T cell-derived psoriatic skin inflammation.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22417311     DOI: 10.1111/j.1600-0625.2012.01462.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  50 in total

1.  MicroRNA-21 promotes Th17 differentiation and mediates experimental autoimmune encephalomyelitis.

Authors:  Gopal Murugaiyan; Andre Pires da Cunha; Amrendra K Ajay; Nicole Joller; Lucien P Garo; Sowmiya Kumaradevan; Nir Yosef; Vishal S Vaidya; Howard L Weiner
Journal:  J Clin Invest       Date:  2015-02-02       Impact factor: 14.808

2.  Expression of miRNA-155, miRNA-223, miRNA-31, miRNA-21, miRNA-125b, and miRNA-146a in the Inflammatory Pathway of Hidradenitis Suppurativa.

Authors:  S Hessam; M Sand; M Skrygan; T Gambichler; F G Bechara
Journal:  Inflammation       Date:  2017-04       Impact factor: 4.092

3.  MicroRNA values in children with rheumatic carditis: a preliminary study.

Authors:  Gokhan Gumus; Dilek Giray; Onur Bobusoglu; Lulufer Tamer; Derya Karpuz; Olgu Hallioglu
Journal:  Rheumatol Int       Date:  2018-05-29       Impact factor: 2.631

Review 4.  Immuno-miRs: critical regulators of T-cell development, function and ageing.

Authors:  Bart-Jan Kroesen; Nato Teteloshvili; Katarzyna Smigielska-Czepiel; Elisabeth Brouwer; Anne Mieke H Boots; Anke van den Berg; Joost Kluiver
Journal:  Immunology       Date:  2015-01       Impact factor: 7.397

Review 5.  The validity of circulating microRNAs in oncology: five years of challenges and contradictions.

Authors:  J Jarry; D Schadendorf; C Greenwood; A Spatz; L C van Kempen
Journal:  Mol Oncol       Date:  2014-03-06       Impact factor: 6.603

6.  miR-320b Is Down-Regulated in Psoriasis and Modulates Keratinocyte Proliferation by Targeting AKT3.

Authors:  Yan Wang; Xiaojing Yu; Lihua Wang; Weiyuan Ma; Qing Sun
Journal:  Inflammation       Date:  2018-12       Impact factor: 4.092

Review 7.  Epigenetics in Non-tumor Immune-Mediated Skin Diseases.

Authors:  M C Ovejero-Benito; E Daudén; Alejandra Reolid; E Muñoz-Aceituno; F Abad-Santos
Journal:  Mol Diagn Ther       Date:  2021-03-01       Impact factor: 4.074

Review 8.  An updated review of mechanotransduction in skin disorders: transcriptional regulators, ion channels, and microRNAs.

Authors:  Jing Wang; Yifan Zhang; Ning Zhang; Chuandong Wang; Tanja Herrler; Qingfeng Li
Journal:  Cell Mol Life Sci       Date:  2015-02-15       Impact factor: 9.261

Review 9.  MicroRNAs in normal and psoriatic skin.

Authors:  Jing Xia; Weixiong Zhang
Journal:  Physiol Genomics       Date:  2013-12-10       Impact factor: 3.107

10.  miR-617 Promotes the Growth of IL-22-Stimulated Keratinocytes Through Regulating FOXO4 Expression.

Authors:  Tao Liu; Xiaomei Feng; Yongmei Liao
Journal:  Biochem Genet       Date:  2020-11-19       Impact factor: 1.890

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.